Neuren (NEU) are another great example of what FDA approval can do to a share price. When the news dropped, the share price was sitting around $7.67. In the 11 weeks since it has hit a high of $15.17 and closed today at $13.84. I hope we can follow a similar path if we get our double approval
SP if both FDA approvals go through, page-26
-
- There are more pages in this discussion • 208 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.06 |
Change
-0.160(4.97%) |
Mkt cap ! $215.7M | |||
| Open | High | Low | Value | Volume |
| $3.17 | $3.17 | $3.05 | $559.2K | 180.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 10230 | $3.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.07 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |